文献速递脊柱关节炎

中轴型脊柱关节炎骶髂关节MRI结构改变与症状及功能的意义

Significance of structural changes in the sacroiliac joints of patients with axial spondyloarthritis detected by MRI related to patients symptoms and functioning.
PubMed 文献 · Ann Rheum Dis · 2021-10-28

本文为叙述性综述,讨论中轴型脊柱关节炎(axSpA)患者骶髂关节(SIJ)MRI检测到的结构改变与患者症状及功能之间关联的有限意义。文中提及TNFi和IL-17拮抗剂可抑制结构损伤、延缓影像学进展,但对此类结构改变评估的临床价值持审慎态度。

要点

  • axSpA主要累及中轴骨骼,最初多侵犯骶髂关节,后续可蔓延至脊柱。
  • TNFi和IL-17拮抗剂可抑制结构损伤,如延缓影像学进展。
  • 综述认为SIJ结构改变与症状及功能关联的意义有限。

核心结论

  • SIJ MRI检测到的结构改变与axSpA患者症状及功能之间关联的临床意义有限。

研究设计与样本

  • 叙述性综述,讨论axSpA患者SIJ结构改变的意义,未报告系统检索范围。

主要发现

  • TNFi治疗至少2年后,CR评估的脊柱新骨形成减少。
  • 依那西普和filgotinib治疗的axSpA患者中观察到SIJ侵蚀和强直减少。

临床怎么用

  • 临床解读axSpA患者SIJ MRI结构改变时,应审慎对待其与症状及功能的关联。

局限性

  • 为叙述性综述,未报告系统检索策略及纳入标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease that manifests primarily in the axial skeleton, initially mostly in the sacroiliac joints (SIJ), usually later spreading to the spine. The disease is characterised by inflammation and new bone formation which are mainly assessed by conventional radiography (CR) and magnetic resonance imaging (MRI). Tumour necrosis factor inhibitors (TNFi) and interleukin-17 antagonists have been shown to be efficacious and efficient in patients with axSpA. This treatment seems to also inhibit structural damage, for example, retard radiographic progression. Indeed, a reduction of new bone formation in the spine, as assessed by CR, has been reported to occur after at least 2 years of therapy with TNFi. Recently, a reduction of erosions and ankylosis in the SIJ has also been observed in axSpA patients treated with etanercept and filgotinib. In this narrative review, we discuss the limited significance of such findings.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Braun J, Kiltz U, Baraliakos X, et al. Significance of structural changes in the sacroiliac joints of patients with axial spondyloarthritis detected by MRI related to patients symptoms and functioning. Ann Rheum Dis. 2021. PMID: 34711586. doi:10.1136/annrheumdis-2021-221406

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。